CIK: 1008317 - Address: C/o Osiris Therapeutics, Inc., 7075 Albert Einstein Drive, Columbia, MD 21046
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11335811-665
P%wins100100100100336783
S%ret112287-1216918
S%wins50050500025

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/16/13 20:58
8/14/13
OSIROsiris Therapeutics, Inc.MDHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTHChairmanM.d11,00011.00171,000714,800D281127168869072878531-14-20-16-25
12/10/12 07:54
12/10/12
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTHChairmanS-4769.521-50014,223I3195522210-1-2-15-561250
11/16/12 06:54
11/15/12
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTHChairmanS-69.341-1014,273I67356-5-26-11-21-951019-73088
11/14/08 16:11
11/14/08
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTHChairmanP.d2,50012.173205114,242D-15462517-14711023823-21-54
12/20/07 08:10
12/19/07
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTP.d9,85312.921763514,807D-53-7-1333-9-32651660
6/8/07 12:04
6/6/07
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTP.d14,00011.3821,2301013,944D-49-10-22-102566128-212
2/26/07 13:09
2/5/07
OSIROsiris Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFriedli PeterMDDTM11823.625507,813I60-21-40-27-13-102-1429-20-23-26

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact